Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Biomatters sells futuristic genome analysis

Biomatters sells futuristic genome analysis package

Today – Biomatters announced the sale of its sophisticated package for helping scientists analyse differences in human genomes which CEO Daniel Batten says could ultimately pave the way for a new generation of drugs which are tailored to a person’s DNA.

The deal is worth around $250,000 over three years to Biomatters, and allows the Auckland University worldwide premiere access to its software. Says Batten “The University is more than a customer, they are a development partner. The plus for us is that we have been able to gain a customer before we take the tool to market internationally – while for the University – they get considerable input into the design of the software and, we hope, the ability to make meaningful research findings before anyone else in the world gains access to the software.

The working title for this product is “iSeek”. Chief Bioinformatician Alexei Drummond says “iSeek is more than a product – it is a framework which integrates 3 key areas that have been holding back genomic science. All bioinformatics complexity is kept under the hood of a front-end that is usable and invaluable to any molecular biology.”

Biomatters, a resident of the Icehouse with its R&D team now co-located at Auckland University, has recently taken on five new developers-interns to increase its R&D effort.

In other recent news, Biomatters presented an abstract at the International Mouse Genome Conference in Seattle, and made a poster-presentation at Ausbiotech in Brisbane Australia.

Last month Biomatters received an Enterprise Development Grant and an Enterprise Network grant to increase their overseas presence and infrastructure. They were also named a “pathfinder” company by New Zealand Trade and Enterprise. Pathfinders are a select group of companies the New Zealand Government have identified as being able to make a difference to the New Zealand economy.

- Ends -

For more information visit www.biomatters.com


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Media Mega Merger: StuffMe Hearing Argues Over Moveable Feast

New Zealand's two largest news publishers are appealing against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Elsewhere:


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:


Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>